Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Clinical trials indicate an average weight loss of around 15%, alongside improvements in metabolic parameters such as blood sugar control and blood pressure
Novo Nordisk funded the clinical trial
HPLC purity and LC-MS identity verified per batch, with the COA available on request
Quick Answer: Wegovy and lisdexamfetamine can be prescribed together for their respective licensed indications, but require careful clinical assessment and close monitoring due to overlapping effects on appetite, cardiovascular parameters, and gastrointestinal function
US$ 22.86
US$ 20.42
US$ 26.72
